北美神经生物标志物市场预测至 2027 年 - COVID-19 影响和按产品进行区域分析（蛋白质组学生物标志物、基因组学生物标志物、代谢组学生物标志物、成像生物标志物等）；应用（阿尔茨海默病、帕金森病、精神分裂症、亨廷顿病、脊髓性肌萎缩症等）；最终用户（制药和生物技术公司、临床诊断、研究组织）和国家/地区
No. of Pages: 139 | Report Code: TIPRE00013306 | Category: Life Sciences
No. of Pages: 139 | Report Code: TIPRE00013306 | Category: Life Sciences
生物标志物是疾病特异性指标。生物技术的进步使得能够测量导致各种神经系统疾病的特定生物标志物，这在以前是不可能的。这些生物标记物的日益普及有助于神经系统疾病的早期检测、微创诊断和更快的药物开发。
北美神经生物标志物市场预计将从 2019 年的 70.5676 亿美元增至 2027 年的 26.1868 亿美元。预计 2020-2027 年该市场的复合年增长率为 13.4%。神经系统疾病患病率的增加和对神经生物标志物研究的日益关注等因素预计将推动市场的增长。然而，神经生物标志物的局限性是阻碍市场增长的主要因素。
基于产品2019年，基因组生物标志物领域占据了最大的市场份额，预计在预测期内将以最快的复合年增长率增长。由于消费者对基因药物益处的认识不断提高以及神经生物标志物领域的技术进步，这一领域可能会出现利润丰厚的增长。此外，采用基因咨询和基因分析进行诊断的趋势转变也可能会促进该领域的增长。遗传生物标志物是重要的模式，可指导更加个性化的倾向和医学分析方法。
按地理位置
• 北美
Strategic insights for North America Neurological Biomarkers involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 7,056.76 Million |
| Market Size by 2027 | US$ 2,618.68 Million |
| Global CAGR (2020 - 2027) | 13.4% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Neurological Biomarkers refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Neurological Biomarkers Market is valued at US$ 7,056.76 Million in 2019, it is projected to reach US$ 2,618.68 Million by 2027.
As per our report North America Neurological Biomarkers Market, the market size is valued at US$ 7,056.76 Million in 2019, projecting it to reach US$ 2,618.68 Million by 2027. This translates to a CAGR of approximately 13.4% during the forecast period.
The North America Neurological Biomarkers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Neurological Biomarkers Market report:
The North America Neurological Biomarkers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Neurological Biomarkers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Neurological Biomarkers Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Neurological Biomarkers Market
